AI Science Tracker
EN

Early Prediction Model for Critical Illness of Hospitalized COVID-19 Patients Based on Machine Learning Techniques.

Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China · 24 May 2022 · medicine

Discovery

Early Prediction Model for Critical Illness of Hospitalized COVID-19 Patients Based on Machine Learning Techniques.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: A LASSO logistic model using admission laboratory data predicted progression to critical COVID-19 in 1,363 development patients and an external 566-patient cohort (AUC 0.83 and 0.84); this is retrospective prognostic evidence, not evidence of improved outcomes.

Technology: L1-penalized logistic regression/LASSO selects admission predictors and estimates risk of later critical illness.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
L1-penalized logistic regression/LASSO selects admission predictors and estimates risk of later critical illness.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fpubh.2022.880999 · https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.880999/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.